Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial.
Diener HC, Ringelstein EB, von Kummer R, Landgraf H, Koppenhagen K, Harenberg J, Rektor I, Csányi A, Schneider D, Klingelhöfer J, Brom J, Weidinger G; PROTECT Trial Group. Diener HC, et al. Among authors: ringelstein eb. Stroke. 2006 Jan;37(1):139-44. doi: 10.1161/01.STR.0000195182.67656.ee. Epub 2005 Nov 23. Stroke. 2006. PMID: 16306456 Clinical Trial.
Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study.
Rolfs A, Fazekas F, Grittner U, Dichgans M, Martus P, Holzhausen M, Böttcher T, Heuschmann PU, Tatlisumak T, Tanislav C, Jungehulsing GJ, Giese AK, Putaala J, Huber R, Bodechtel U, Lichy C, Enzinger C, Schmidt R, Hennerici MG, Kaps M, Kessler C, Lackner K, Paschke E, Meyer W, Mascher H, Riess O, Kolodny E, Norrving B; Stroke in Young Fabry Patients (sifap) Investigators. Rolfs A, et al. Stroke. 2013 Feb;44(2):340-9. doi: 10.1161/STROKEAHA.112.663708. Epub 2013 Jan 10. Stroke. 2013. PMID: 23306324 Clinical Trial.
Toward a multimodal neuroprotective treatment of stroke.
Rogalewski A, Schneider A, Ringelstein EB, Schäbitz WR. Rogalewski A, et al. Among authors: ringelstein eb. Stroke. 2006 Apr;37(4):1129-36. doi: 10.1161/01.STR.0000209330.73175.34. Epub 2006 Mar 9. Stroke. 2006. PMID: 16527996 Review.
Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial.
England TJ, Bath PM, Sare GM, Geeganage C, Moulin T, O'Neill D, Woimant F, Christensen H, De Deyn P, Leys D, Ringelstein EB; TAIST Investigators. England TJ, et al. Among authors: ringelstein eb. Stroke. 2010 Dec;41(12):2834-9. doi: 10.1161/STROKEAHA.109.573063. Epub 2010 Oct 28. Stroke. 2010. PMID: 21030711 Clinical Trial.
Imaging Markers of Brain Frailty and Outcome in Patients With Acute Ischemic Stroke.
Bu N, Khlif MS, Lemmens R, Wouters A, Fiebach JB, Chamorro A, Ringelstein EB, Norrving B, Laage R, Grond M, Wilms G, Brodtmann A, Thijs V. Bu N, et al. Among authors: ringelstein eb. Stroke. 2021 Mar;52(3):1004-1011. doi: 10.1161/STROKEAHA.120.029841. Epub 2021 Jan 28. Stroke. 2021. PMID: 33504185 Clinical Trial.
Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
Geeganage C, Tracy M, England T, Sare G, Moulin T, Woimant F, Christensen H, De Deyn PP, Leys D, O'Neill D, Ringelstein EB, Bath PM; for TAIST Investigators. Geeganage C, et al. Among authors: ringelstein eb. Stroke. 2011 Feb;42(2):491-3. doi: 10.1161/STROKEAHA.110.596163. Epub 2010 Dec 23. Stroke. 2011. PMID: 21183747 Clinical Trial.
511 results